CardioFocus has filed a notice of an exempt offering of securities to raise $31,755,859.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, CardioFocus is raising $31,755,859.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Burke Barrett played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About CardioFocus
CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia. The companys FDA-approved HeartLight Endoscopic Ablation System has successfully treated more than 10,000 patients in the United States, Europe and Japan. The HeartLight System is a revolutionary catheter ablation technology that along with direct visualization and titratable laser energy, represents a new standard for AFib ablation. CardioFocus is headquartered in Marlborough, MA.
To learn more about CardioFocus, visit http://www.cardiofocus.com/
Contact:
Burke Barrett, President and Chief Executive Officer
508-658-7200
https://www.linkedin.com/in/burke-t-barrett-49a79b7/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.